The need to revisit ochratoxin A risk in light of diabetes, obesity, and chronic kidney disease prevalence
- 1 May 2017
- journal article
- research article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 103, 79-85
Abstract
No abstract availableKeywords
Funding Information
- United States Department of Agriculture National Institute of Food and Agriculture (2011-67005-20676)
This publication has 36 references indexed in Scilit:
- Type 2 diabetes mellitusNature Reviews Disease Primers, 2015
- Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) stagingBMC Research Notes, 2014
- Global estimates of diabetes prevalence for 2013 and projections for 2035Diabetes Research and Clinical Practice, 2014
- Ochratoxin A and Human Health Risk: A Review of the EvidenceCritical Reviews in Food Science and Nutrition, 2013
- Quantitative assessment of risk associated with dietary intake of mycotoxin ochratoxin A on the adult inhabitants in Shanghai city of P.R. ChinaFood Control, 2013
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure modelCritical Reviews in Toxicology, 2011
- Stability of mycotoxins during food processingInternational Journal of Food Microbiology, 2007
- Association between Obesity and Chronic Kidney Disease in Japanese: Differences in Gender and Hypertensive Status?Hypertension Research, 2007
- Does Human Ochratoxin A Aggravate Proteinuria in Patients with Chronic Renal Disease?Renal Failure, 2004